ABL1 and lymphoid neoplasm: A clonal population with abnormal cytogenetics or somatic mutation(s) but no S3FB1 mutation, BCR-ABL1 translocation, or other genetic abnormalities of myeloid/lymphoid neoplasms with eosinophilia and tyrosine kinase gene fusion should be identified.